Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth
NEW YORK, May 21, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p01188011/Travel-Vaccines-Market-to-2019---Hepatitis-A-Japanese-Encephalitis-and-Meningococcal-Vaccine-Segments-to-Drive-Growth.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication
Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth
Summary
The leading business intelligence provider GBI Research has released its latest research report, entitled "Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth". The report provides insights into the vaccines in the Travel Vaccines market including market forecasts up to 2019. It provides an in-depth analysis of the travel vaccines, as well as insights into the Travel Vaccines R&D pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global Travel Vaccines market. The report analyzes the market for Travel Vaccines in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. In addition, it provides overview of vaccines market in India, China and Australia including regulatory frameworks and profiles of the top companies, deals and pipeline analysis. The report discusses the global pipeline for Travel Vaccines across various stages of development. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.
GBI Research found that the Travel Vaccines market in the top seven markets was valued at $1,343m in 2012, increasing at a Compound Annual Growth Rate (CAGR) of 11% during the 2007–2012 historic period. The market is projected to witness growth of 7.5% during the 2012–2019 forecast period to reach $2,224m. The growth in the Travel Vaccines market is driven by increased uptake of hepatitis A vaccines, which is expected to grow at a CAGR of 7% during the forecast period and reach $423m in 2019 from $264m in 2012.
Scope
- Annualized market data for the Travel Vaccines market from 2007 to 2012, forecast forward to 2019.
- Analysis of the Travel Vaccines market in the leading geographies of the world, which includes the US, the UK, Germany, France, Italy, Spain, and Japan.
- Market characterization of the Travel Vaccines market including market size, cost of vaccination.
- Key drivers and barriers that have a significant impact on the market.
- Coverage of pipeline molecules in various phases of vaccine development.
- Competitive benchmarking of leading companies. Key companies studied in this report are GlaxoSmithKline, Sanofi, Pfizer, Merck and Novartis.
- Key M&A activities and licensing agreements that have taken place between 2009 and up to January 2013 in the global Travel Vaccines market.
Reasons to buy
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the potential region and Travel Vaccines market segments poised for strong growth.
- Create a more tailored country strategy through the understanding of key drivers and barriers of the global Travel Vaccines market.
- Develop key strategic initiatives by understanding the key focus areas and top selling products of leading companies.
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships
Table of Contents
1 Table of CContents 6
1.1 List of Tables 10
1.2 List of Figures 12
2 Travel Vaccines Market to 2019: Introduction 14
2.1 Overview 14
3 Travel Vaccines Market to 2019: Overview 15
3.1 Vaccine-Preventable Diseases 15
3.1.1 Types of Vaccines 16
3.2 Regulatory Framework 17
3.2.1 US 17
3.2.2 UK 17
3.2.3 France 18
3.2.4 Germany 18
3.2.5 Italy 18
3.2.6 Spain 19
3.2.7 Japan 19
3.3 Vaccine Manufacturing Process 20
4 Travel Vaccines Market to 2019: Market Characterization and Forecast 21
4.1 Revenue Forecast 21
4.2 Market Share by Vaccine Type 22
4.3 Market Share by Geography 23
4.4 Traveling Population 24
4.5 Drivers 25
4.5.1 Aging Population and Increase in Global Tourist Traffic 25
4.5.2 Novel Vaccine Technologies 25
4.5.3 New and Novel Vaccines Launches Targeting High-Risk Populations 25
4.6 Restraints 26
4.6.1 Vaccine Supply Shortage Issues 26
4.6.2 High Start-up Costs and Special Technical Expertise Requirements for Vaccine Production 26
4.6.3 Public Acceptance 26
4.6.4 Austerity Measures Leading to a Drop in Healthcare Funding 26
5 Travel Vaccines Market to 2019: Hepatitis A Vaccines 27
5.1 Disease Overview 27
5.2 Market Forecasts 28
5.2.1 US 28
5.2.2 Top Five European Countries 29
5.2.3 Japan 30
5.3 Cost of Vaccination 31
5.3.1 US 31
5.3.2 Top Five European Countries 31
5.3.3 Japan 32
5.4 Pipeline Analysis 32
5.4.1 Phase III (Inactive) 33
5.4.2 Preclinical and Discovery (Inactive) 33
6 Travel Vaccines Market to 2019: Hepatitis B Vaccines 34
6.1 Disease Overview 34
6.2 Market Forecasts 35
6.2.1 US 35
6.2.2 Top Five European Countries 36
6.2.3 Japan 37
6.3 Cost of Vaccination 38
6.3.1 US 38
6.3.2 Top Five European Countries 38
6.3.3 Japan 39
6.4 Pipeline Analysis 39
6.4.1 Registration and Phase III 40
6.4.2 Phase II 40
6.4.3 Phase I 40
6.4.4 Preclinical and Discovery 41
7 Travel Vaccines Market to 2019: Japanese Encephalitis Vaccines 42
7.1 Disease Overview 42
7.2 Market Forecasts 43
7.2.1 US 43
7.2.2 Top Five European Countries 44
7.2.3 Japan 45
7.3 Cost of Vaccination 46
7.3.1 US 46
7.3.2 Top Five European Countries 46
7.3.3 Japan 47
7.4 Pipeline Analysis 47
7.4.1 Registration 48
7.4.2 Preclinical and Discovery 48
8 Travel Vaccines Market to 2019: Meningococcal Vaccines 49
8.1 Disease Overview 49
8.2 Market Forecasts 50
8.2.1 US 50
8.2.2 Top Five European Countries 51
8.3 Cost of Vaccination 52
8.3.1 US 52
8.3.2 Top Five European Countries 52
8.4 Pipeline Analysis 53
8.4.1 Registration and Phase III 53
8.4.2 Phase II 54
8.4.3 Preclinical and Discovery 54
9 Travel Vaccines Market to 2019: Rabies Vaccines 55
9.1 Disease Overview 55
9.2 Market Forecasts 56
9.2.1 US 56
9.2.2 Top Five European Countries 57
9.2.3 Japan 58
9.3 Cost of Vaccination 59
9.3.1 US 59
9.3.2 Top Five European Countries 59
9.3.3 Japan 60
9.4 Pipeline Analysis 60
9.4.1 Phase II 61
9.4.2 Phase I 61
9.4.3 Preclinical 61
10 Travel Vaccines Market to 2019: Typhoid Vaccines 62
10.1 Disease Overview 62
10.2 Market Forecasts 63
10.2.1 US 63
10.2.2 Top Five European Countries 64
10.3 Cost of Vaccination 65
10.3.1 US 65
10.3.2 Top Five European Countries 65
10.4 Pipeline Analysis 66
10.4.1 Phase II 66
10.4.2 Preclinical 66
11 Travel Vaccines Market to 2019: Yellow Fever Vaccines 67
11.1 Disease Overview 67
11.2 Market Forecasts 68
11.2.1 US 68
11.2.2 Top Five European Countries 69
11.2.3 Japan 70
11.3 Cost of Vaccination 71
11.3.1 US 71
11.3.2 Top Five European Countries 71
11.3.3 Japan 72
11.4 Pipeline Analysis 72
11.4.1 Phase III 73
11.4.2 Phase I 73
11.4.3 Preclinical and Discovery 73
12 Travel Vaccines Market to 2019: Competitive Landscape 74
12.1 Introduction 74
12.2 Major Company Profiles 74
12.2.1 GlaxoSmithKline 74
12.2.2 Sanofi 76
12.2.3 Pfizer 77
12.2.4 Merck 78
12.2.5 Novartis 79
13 Travel Vaccines Market to 2019: Strategic Consolidations 80
13.1 Deals by Year 80
13.2 Deals by Type 81
13.3 Deals by Value 82
13.4 Deals by Geography 83
13.5 Summary of Major M&A Deals 83
13.5.1 Gilead Sciences Completes Acquisition of Pharmasset for $11.2 Billion 83
13.5.2 Johnson & Johnson Acquires Crucell 84
13.6 Summary of Major Licensing Deals 84
13.6.1 Intercell Enters into Licensing Agreement with Novartis for IC51 84
13.6.2 Gilead Sciences Enters into Licensing Agreement with GlobeImmune 84
14 Vaccines in Asia-Pacific – India, China and Australia: Overview 85
14.1 India 85
14.1.1 Regulatory Framework 85
14.1.2 Major Company Profiles 91
14.2 Recent Developments 92
14.2.1 Biological E. Launches Japanese Encephalitis Vaccine Jeev in India – September 2012 92
14.2.2 Approvals by Central Drugs Standard Control Organization 92
14.3 China 92
14.3.1 Regulatory Framework 92
14.3.2 Expanded Programme on Immunization 94
14.3.3 Major Company Profiles 95
14.4 Australia 97
14.4.1 Regulatory Framework 97
14.4.2 Designated Vaccines and Circumstances in which Vaccines may be Provided 98
14.4.3 Immunization Schedule 104
14.4.4 Major Company Profiles 105
14.4.5 Recent Developments 106
14.5 Vaccines in Emerging Markets: Strategic Consolidations 107
14.5.1 Deals by Year 107
14.5.2 Deals by Type 108
14.5.3 Deals by Value 109
14.6 Vaccines in Emerging Markets: Pipeline by Phase 110
15 Travel Vaccines Market to 2019: Appendix 111
15.1 Market Definitions 111
15.2 Abbreviations 111
15.3 Bibliography 112
15.4 Research Methodology 113
15.4.1 Coverage 113
15.4.2 Secondary Research 113
15.4.3 Primary Research 114
15.4.4 Model for Estimation of Vaccine Market 114
15.5 Geographical Landscape 116
15.6 Pipeline Analysis 116
15.7 Competitive Landscape 116
15.7.1 Expert Panel Validation 116
15.8 Contact Us 116
15.9 Disclaimer 116
List of Tables
Table 1: Travel Vaccines Market, Top Seven Markets, Vaccine-Preventable Diseases, 2012 15
Table 2: Travel Vaccines Market, Top Seven Markets, Traveler Population (million), 2007–2012 24
Table 3: Travel Vaccines Market, Top Seven Markets, Traveler Population Forecast (million), 2012–2019 25
Table 4: Travel Vaccines Market, US, Hepatitis A Vaccines, Revenue ($m), 2007–2012 28
Table 5: Travel Vaccines Market, US, Hepatitis A Vaccines, Revenue Forecast ($m), 2012–2019 28
Table 6: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Revenue ($m), 2007–2012 29
Table 7: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Revenue Forecast ($m), 2012–2019 29
Table 8: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Revenue ($m), 2007–2012 30
Table 9: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Revenue Forecast ($m), 2012–2019 30
Table 10: Travel Vaccines Market, US, Hepatitis A Vaccines, Cost ($), 2007–2012 31
Table 11: Travel Vaccines Market, US, Hepatitis A Vaccines, Cost ($), 2012–2019 31
Table 12: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Cost ($), 2007–2012 31
Table 13: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Cost Forecast ($), 2012–2019 31
Table 14: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Cost ($), 2007–2012 32
Table 15: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Cost Forecast ($), 2012–2019 32
Table 16: Travel Vaccines Market, Global, Hepatitis A Vaccines, Phase III (Inactive) Pipeline, 2012 33
Table 17: Travel Vaccines Market, Global, Hepatitis A Vaccines, Preclinical and Discovery (Inactive) Pipeline, 2012 33
Table 18: Travel Vaccines Market, US, Hepatitis B Vaccines, Revenue ($m), 2007–2012 35
Table 19: Travel Vaccines Market, US, Hepatitis B Vaccines, Revenue Forecast ($m), 2012–2019 35
Table 20: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Revenue ($m), 2007–2012 36
Table 21: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Revenue Forecast ($m), 2012–2019 36
Table 22: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Revenue ($m), 2007–2012 37
Table 23: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Revenue Forecast ($m), 2012–2019 37
Table 24: Travel Vaccines Market, US, Hepatitis B Vaccines, Cost ($), 2007–2012 38
Table 25: Travel Vaccines Market, US, Hepatitis B Vaccines, Cost Forecast ($), 2012–2019 38
Table 26: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Cost ($), 2007–2012 38
Table 27: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Cost ($), 2012–2019 38
Table 28: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Cost ($), 2007–2012 39
Table 29: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Cost Forecast ($), 2012–2019 39
Table 30: Travel Vaccines Market, Global, Hepatitis B Vaccines, Registration and Phase III Pipeline, 2012 40
Table 31: Travel Vaccines Market, Global, Hepatitis B Vaccines, Phase II Pipeline, 2012 40
Table 32: Travel Vaccines Market, Global, Hepatitis B Vaccines, Phase I Pipeline, 2012 40
Table 33: Travel Vaccines Market, Global, Hepatitis B Vaccines, Preclinical and Discovery Pipeline, 2012 41
Table 34: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Revenue ($m), 2007–2012 43
Table 35: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2012–2019 43
Table 36: Travel Vaccines Market, Top Five European Countries, Japanese Encephalitis Vaccines, Revenue ($m), 2007–2012 44
Table 37: Travel Vaccines Market to 2019, Japanese Encephalitis Vaccines, Top Five European Countries, Revenue Forecast ($m), 2012–2019 44
Table 38: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Revenue ($m), 2007–2012 45
Table 39: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2012–2019 45
Table 40: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Cost ($), 2007–2012 46
Table 41: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Cost Forecast ($), 2012–2019 46
Table 42: Travel Vaccines Market, Top Five European Countries, Japanese Encephalitis Vaccines, Cost ($), 2007–2012 46
Table 43: Travel Vaccines Market, Top Five European Countries, Japanese Encephalitis Vaccines, Cost Forecast ($), 2012–2019 46
Table 44: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Cost ($), 2007–2012 47
Table 45: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Cost Forecast ($), 2012–2019 47
Table 46: Travel Vaccines Market, Global, Japanese Encephalitis Vaccines, Registration, 2012 48
Table 47: Travel Vaccines Market, Global, Japanese Encephalitis Vaccines, Preclinical and Discovery, 2012 48
Table 48: Travel Vaccines Market, US, Meningococcal Vaccines, Revenue ($m), 2007–2012 50
Table 49: Travel Vaccines Market, US, Meningococcal Vaccines, Revenue Forecast ($m), 2012–2019 50
Table 50: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Revenue ($m), 2007–2012 51
Table 51: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Revenue Forecast ($m), 2012–2019 51
Table 52: Travel Vaccines Market, US, Meningococcal Vaccines, Cost ($), 2007–2012 52
Table 53: Travel Vaccines Market, US, Meningococcal Vaccines, Cost Forecast ($), 2012–2019 52
Table 54: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Cost ($), 2007–2012 52
Table 55: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Cost Forecast ($), 2012–2019 52
Table 56: Travel Vaccines Market, Global, Meningococcal Vaccines, Registration and Phase III Pipeline, 2012 53
Table 57: Travel Vaccines Market, Global, Meningococcal Vaccines, Phase II Pipeline, 2012 54
Table 58: Travel Vaccines Market, Global, Meningococcal Vaccines, Preclinical Pipeline, 2012 54
Table 59: Travel Vaccines Market, US, Rabies Vaccines, Revenue ($m), 2007–2012 56
Table 60: Travel Vaccines Market, US, Rabies Vaccines, Revenue Forecast ($m), 2012–2019 56
Table 61: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Revenue ($m), 2007–2012 57
Table 62: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Revenue Forecast ($m), 2012–2019 57
Table 63: Travel Vaccines Market, Japan, Rabies Vaccines, Revenue ($m), 2007–2012 58
Table 64: Travel Vaccines Market, Japan, Rabies Vaccines, Revenue Forecast ($m), 2012–2019 58
Table 65: Travel Vaccines Market, US, Rabies Vaccines, Cost ($), 2007–2012 59
Table 66: Travel Vaccines Market, US, Rabies Vaccines, Cost Forecast ($), 2012–2019 59
Table 67: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Cost ($), 2007–2012 59
Table 68: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Cost Forecast ($), 2012–2019 59
Table 69: Travel Vaccines Market, Japan, Rabies Vaccines, Cost ($), 2007–2012 60
Table 70: Travel Vaccines Market, Japan. Rabies Vaccines, Cost Forecast ($), 2012–2019 60
Table 71: Travel Vaccines Market, Global, Rabies Vaccines, Phase II Pipeline, 2012 61
Table 72: Travel Vaccines Market, Global, Rabies Vaccines, Phase I Pipeline, 2012 61
Table 73: Travel Vaccines Market, Global, Rabies Vaccines, Preclinical Pipeline, 2012 61
Table 74: Travel Vaccines Market, US, Typhoid Vaccines, Revenue ($m), 2007–2012 63
Table 75: Travel Vaccines Market, US, Typhoid Vaccines, Revenue Forecast ($m), 2012–2019 63
Table 76: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Revenue ($m), 2007–2012 64
Table 77: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Revenue Forecast ($m), 2012–2019 64
Table 78: Travel Vaccines Market, US, Typhoid Vaccines, Cost ($), 2007–2012 65
Table 79: Travel Vaccines Market, US, Typhoid Vaccines, Cost Forecast ($), 2012–2019 65
Table 80: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Cost ($), 2007–2012 65
Table 81: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Cost Forecast ($), 2012–2019 65
Table 82: Travel Vaccines Market, Global, Typhoid Vaccines, Phase II Pipeline, 2012 66
Table 83: Travel Vaccines Market, Global, Typhoid Vaccines, Preclinical Pipeline, 2012 66
Table 84: Travel Vaccines Market, US, Yellow Fever Vaccines, Revenue ($m), 2007–2012 68
Table 85: Travel Vaccines Market, US, Yellow Fever Vaccines, Revenue Forecast ($m), 2012–2019 68
Table 86: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Revenue ($m), 2007–2012 69
Table 87: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Revenue Forecast ($m), 2012–2019 69
Table 88: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Revenue ($m), 2007–2012 70
Table 89: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Revenue Forecast ($m), 2012–2019 70
Table 90: Travel Vaccines Market, US, Yellow Fever Vaccines, Cost ($), 2007–2012 71
Table 91: Travel Vaccines Market, US, Yellow Fever Vaccines, Cost Forecast ($), 2012–2019 71
Table 92: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Cost ($), 2007–2012 71
Table 93: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Cost Forecast ($), 2012–2019 71
Table 94: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Cost ($), 2007–2012 72
Table 95: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Cost Forecast ($), 2012–2019 72
Table 96: Travel Vaccines Market, Global, Yellow Fever Vaccines, Phase III, 2012 73
Table 97: Travel Vaccines Market, Global, Yellow Fever Vaccines, Phase I, 2012 73
Table 98: Travel Vaccines Market, Global, Yellow Fever Vaccines, Preclinical and Discovery, 2012 73
Table 99: Travel Vaccines Market, India, Immunization Schedule, 2012 87
Table 100: Travel Vaccines Market, India, Major Vaccine Brands by Indication, 2012 88
Table 101: Travel Vaccines Market, China, Policies, 2012 95
Table 102: Travel Vaccines Market, Australia, Designated Bacterial Vaccines and Circumstances in which Vaccines may be Provided, 2011 98
Table 103: Travel Vaccines Market, Australia, Designated Viral Vaccines and Circumstances in which Vaccines may be Provided, 2011 100
Table 104: Travel Vaccines Market, Australia, Designated Combined Bacterial and Viral Vaccines and Circumstances in which Vaccines may be Provided, 2011 103
Table 105: Travel Vaccines Market, Australia, Immunization Schedule, 2012 104
Table 106: Travel Vaccines Market, Emerging Markets, Pipeline by Phase, 2012 110
List of Figures
Figure 1: Travel Vaccines Market, Global, Vaccine Types, 2012 16
Figure 2: Travel Vaccines Market, Global, Vaccine Manufacturing Process, 2012 20
Figure 3: Travel Vaccines Market, Top Seven Markets, Revenue Forecast ($m), 2007–2019 21
Figure 4: Travel Vaccines Market, Top Seven Markets, Market Share by Vaccine Type (%), 2012 22
Figure 5: Travel Vaccines Market, Top Seven Markets, Market Share by Geography (%), 2012 23
Figure 6: Travel Vaccines Market, Top Seven Markets, Traveling Population (million), 2007–2019 24
Figure 7: Travel Vaccines Market, Global, Geographical Distribution of Hepatitis A, 2012 27
Figure 8: Travel Vaccines Market, US, Hepatitis A Vaccines, Revenue Forecast ($m), 2007–2019 28
Figure 9: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Revenue Forecast ($m), 2007–2019 29
Figure 10: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Revenue Forecast ($m), 2007–2019 30
Figure 11: Travel Vaccines Market, Global, Hepatitis A Vaccines, Pipeline by Phase (%), 2012 32
Figure 12: Travel Vaccines Market, Global, Geographical Distribution of Hepatitis B, 2012 34
Figure 13: Travel Vaccines Market, US, Hepatitis B Vaccines, Revenue Forecast ($m), 2007–2019 35
Figure 14: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Revenue Forecast ($m), 2007–2019 36
Figure 15: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Revenue Forecast ($m), 2007–2019 37
Figure 16: Travel Vaccines Market, Global, Hepatitis B Vaccines, Pipeline by Phase (%), 2012 39
Figure 17: Travel Vaccines Market, Global, Geographical Distribution of Japanese Encephalitis, 2012 42
Figure 18: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2007–2019 43
Figure 19: Travel Vaccines Market, Top Five European Countries, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2007–2019 44
Figure 20: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2007–2019 45
Figure 21: Travel Vaccines Market, Global, Japanese Encephalitis Vaccines, Pipeline by Phase (%), 2012 47
Figure 22: Travel Vaccines Market, Global, Geographical Distribution of Meningococcal Meningitis, 2012 49
Figure 23: Travel Vaccines Market, US, Meningococcal Vaccines, Revenue Forecast ($m), 2007–2019 50
Figure 24: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Revenue Forecast ($m), 2007–2019 51
Figure 25: Travel Vaccines Market, Global, Meningococcal Vaccines, Pipeline by Phase (%), 2012 53
Figure 26: Travel Vaccines Market, Global, Geographical Distribution of Rabies, 2012 55
Figure 27: Travel Vaccines Market, US, Rabies Vaccines, Revenue Forecast ($m), 2007–2019 56
Figure 28: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Revenue Forecast ($m), 2007–2019 57
Figure 29: Travel Vaccines Market, Japan. Rabies Vaccines, Revenue Forecast ($m), 2007–2019 58
Figure 30: Travel Vaccines Market, Global, Rabies Vaccines, Pipeline by Phase (%), 2012 60
Figure 31: Travel Vaccines Market, Global, Geographical Distribution of Typhoid, 2012 62
Figure 32: Travel Vaccines Market, US, Typhoid Vaccines, Revenue Forecast ($m), 2007–2019 63
Figure 33: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Revenue Forecast ($m), 2007–2019 64
Figure 34: Travel Vaccines Market, Global, Typhoid Vaccines, Pipeline by Phase (%), 2012 66
Figure 35: Travel Vaccines Market, Global, Geographical Distribution of Yellow Fever, 2012 67
Figure 36: Travel Vaccines Market, US, Yellow Fever Vaccines, Revenue Forecast ($m), 2007–2019 68
Figure 37: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Revenue Forecast ($m), 2007–2019 69
Figure 38: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Revenue Forecast ($m), 2007–2019 70
Figure 39: Travel Vaccines Market, Global, Yellow Fever Vaccines, Pipeline by Phase (%), 2012 72
Figure 40: GlaxoSmithKline, Travel Vaccines Market, SWOT Analysis, 2012 75
Figure 41: Sanofi, Travel Vaccines Market, SWOT Analysis, 2012 76
Figure 42: Pfizer, Travel Vaccines Market, SWOT Analysis, 2012 77
Figure 43: Merck, Travel Vaccines Market, SWOT Analysis, 2012 78
Figure 44: Novartis, Travel Vaccines Market, SWOT Analysis, 2012 79
Figure 45: Travel Vaccines Market, Global, Strategic Consolidations, Deals by Year, 2009–2013 80
Figure 46: Travel Vaccines Market, Global, Strategic Consolidations, Deals by Type, 2008–2013 81
Figure 47: Travel Vaccines Market, Global, Strategic Consolidations, Deals by Value, 2008–2013 82
Figure 48: Travel Vaccines Market, Global, Strategic Consolidations, Deals by Geography, 2008–2013 83
Figure 49: Vaccines in Emerging Markets, India, National Rural Health Mission, 2011 86
Figure 50: Vaccines in Emerging Markets, Deals by Year, 2009–2013 107
Figure 51: Travel Vaccines Market, Emerging Markets, Deals by Type (%), 2009–2013 108
Figure 52: Travel Vaccines Market, Emerging Markets, Deals by Value ($m), 2009–2013 109
Figure 53: Travel Vaccines Market, Emerging Markets, Pipeline by Phase (%), 2012 110
Figure 54: GBI Research Market Forecasting Model 115
Companies Mentioned
GlaxoSmithKline
Sanofi
Pfizer
Merck
Novartis
To order this report:
Drug_and_Medication Industry: Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
Share this article